Back to Articles
Guides9 min readJuly 25, 2026
Innerwell Review 2026: At-Home Ketamine Therapy, Safety & Costs
Innerwell's at-home ketamine program reviewed—the supervised clinical model, the FDA's compounded-ketamine context, billing complaints, and who should not consider this.
By Med Consumer Watch Team
Innerwell (helloinnerwell.com) offers at-home ketamine-assisted therapy for depression and anxiety: psychiatric evaluation, compounded ketamine shipped to your home, and treatment sessions supervised by clinicians over live video, paired with integration therapy. This is the most safety-sensitive category we cover, so this review leads with the regulatory and clinical context before the consumer details. If you're in crisis, call or text 988 now—no signup flow is the right first step. This review contains affiliate links; the assessment is our own.
The Regulatory Context You Must Understand First
Ketamine is FDA-approved as an anesthetic—not for depression. Esketamine (Spravato) is FDA-approved for treatment-resistant depression, but only administered in certified clinics under direct observation. The compounded oral ketamine used by at-home programs like Innerwell is not FDA-approved for any psychiatric use, and the FDA has publicly warned about safety risks of compounded ketamine for at-home treatment—including misuse and abuse potential, increased blood pressure, respiratory depression, and psychiatric events—precisely because home settings lack in-person monitoring. Evidence for oral ketamine in depression is promising but far thinner than for clinic-administered forms. Any honest consideration of Innerwell starts from that baseline.
Innerwell's Model: The More Supervised Version
Within the at-home category, Innerwell's structure addresses more of the FDA's concerns than most competitors: comprehensive psychiatric screening before any prescription, licensed clinicians overseeing treatment, and—its key differentiator—real-time video supervision during dosing sessions rather than the take-it-alone model some rivals use, plus integration therapy around the sessions. That's meaningfully closer to clinical practice than unmonitored at-home dosing. It does not make compounded ketamine FDA-approved, and it still depends on honest screening: ketamine is generally inappropriate for people with a history of psychosis, uncontrolled hypertension or serious cardiovascular disease, substance use disorder, or pregnancy—and dissociative experiences can be distressing.
Costs, Complaints, and Availability
Program pricing runs on multi-session packages billed through the platform (the landing funnel gates exact figures—get your all-in total in writing). The complaint record is thin but pointed: BBB complaints report patients charged before completing screening and facing refund delays when not accepted, and at least one reviewer described the billing as opaque, with the real total exceeding the advertised figure once required clinician visits were added. There's no substantial Trustpilot record or BBB accreditation. Availability is limited: program terms exclude twenty-two states as of July 2026 (including AL, AK, DE, HI, IN, KY, LA, ME, MD, MS, MO, NE, NM, NC, ND, OK, RI, SC, SD, VT, WV, WY)—check before starting intake.
Before paying anything: get the all-in program cost in writing (including required visits), confirm the refund terms if screening rejects you, and verify the prescribing clinician's license. Do not use ketamine therapy as a substitute for crisis care—call or text 988 if you're in crisis.
Common Questions
Quick answers to what buyers actually search:
- Is Innerwell legit? — A real, psychiatrist-led program with more supervision than most at-home ketamine rivals—operating in a category the FDA has warned about, with billing complaints to guard against.
- Is at-home ketamine FDA-approved? — No. Compounded ketamine is not FDA-approved for psychiatric use; only in-clinic esketamine (Spravato) is approved for treatment-resistant depression.
- How much does Innerwell cost? — Package pricing is funnel-gated; complaints cite totals above advertised figures once required visits are added—get the all-in number in writing.
- Who should not use ketamine therapy? — People with psychosis history, uncontrolled blood pressure or serious heart disease, substance use disorder, or pregnancy—and anyone in acute crisis (call/text 988 instead).
- Where isn't Innerwell available? — Twenty-two states as of July 2026; check the list before intake.
- Innerwell vs Mindbloom? — Innerwell's video-supervised dosing is the more conservative model; compare supervision, therapy pairing, and all-in cost rather than headline prices.
The Bottom Line
Verdict: 7.0/10—the most clinically conservative design in a category that earns its warnings, from an operator whose billing paperwork draws the complaints its medicine doesn't. If you and a psychiatrist—yours, not just theirs—conclude supervised at-home ketamine is appropriate for your treatment-resistant depression, Innerwell's screening-plus-video-supervision model is the version of this we'd want to see; go in with the all-in cost and rejection-refund terms in writing. If you're weighing it as a first-line option, start with conventional care instead—and if you're in crisis, call or text 988 now. This review is informational only, not medical advice. Checked July 25, 2026; terms change.
Sources & References
- Innerwell — Official Site
- FDA — Compounded Ketamine Safety Communication
- BBB — Innerwell profile (New York)
- 988 Suicide & Crisis Lifeline
Medical Disclaimer
This article is for informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before making decisions about your health or medications. Individual experiences may vary.